Search

Now showing items 1-10 of 11

Treatment of Women with Multiple Sclerosis Planning Pregnancy

Krysko, KM; Bove, R; Dobson, R; Jokubaitis, V; Hellwig, K (2021-04)

COVID-19 in people with multiple sclerosis: A global data sharing initiative

Peeters, LM; Parciak, T; Walton, C; Geys, L; Moreau, Y; De Brouwer, E; Raimondi, D; Pirmani, A; Kalincik, T; Edan, G;... (2020-09)

MS, pregnancy and COVID-19

Yam, C; Jokubaitis, V; Hellwig, K; Dobson, R (2020-09)

Sex effects across the lifespan in women with multiple sclerosis

Krysko, KM; Graves, JS; Dobson, R; Altintas, A; Amato, MP; Bernard, J; Bonavita, S; Bove, R; Cavalla, P; Clerico, M;... (2020-06)

Optimization of extraction process of Sarcandra glabra by combination of entropy weight method with Box- Behnken response surface method

Krysko, KM; Dobson, R; Alroughani, R; Amato, MP; Bove, R; Ciplea, AI; Fragoso, Y; Houtchens, M; Jokubaitis, VG; Magyari, M;... (2023)

The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021

Tur, C; Dubessy, A-L; Otero-Romero, S; Amato, MP; Derfuss, T; Di Pauli, F; Iacobaeus, E; Mycko, M; Abboud, H; Achiron, A;... (2022)

The Multiple Sclerosis Data Alliance Catalogue: Enabling Web-Based Discovery of Metadata from Real-World Multiple Sclerosis Data Sources.

Geys, L; Parciak, T; Pirmani, A; McBurney, R; Schmidt, H; Malbaša, T; Ziemssen, T; Bergmann, A; Rojas, JI; Cristiano, E;... (2021)

BACKGROUND: One of the major objectives of the Multiple Sclerosis Data Alliance (MSDA) is to enable better discovery of multiple sclerosis (MS) real-world data (RWD). METHODS: We implemented the MSDA Catalogue, which is ...

Ocrelizumab during pregnancy and lactation: Rationale and design of the MINORE and SOPRANINO studies in women with MS and their infants

Bove, R; Hellwig, K; Pasquarelli, N; Borriello, F; Dobson, R; Oreja-Guevara, C; Lin, C-J; Zecevic, D; Craveiro, L; McElrath, T;... (2022)

Rationale and design of a phase 4 study exploring B-cell levels and immune responses in infants born to women with MS who were exposed to ocrelizumab up to 6 months before or during the first trimester of pregnancy (the MINORE study)

Hellwig, K; Pasquarelli, N; Borriello, F; Bove, R; Dobson, R; Oreja-Guevara, C; Vukusic, S; Wei, W; Zecevic, D; Craveiro, L;... (2021)

B-cell levels and immunity in breastfed infants of women with MS treated with ocrelizumab: design of a phase 4 study (SOPRANINO)

Bove, R; Pasquarelli, N; Borriello, F; Dobson, R; Hellwig, K; McElrath, T; Oreja-Guevara, C; Wei, W; Zecevic, D; Craveiro, L;... (2021)